Page last updated: 2024-10-25

desipramine and Agranulocytosis

desipramine has been researched along with Agranulocytosis in 3 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hardin, TC1
Conrath, FC1
Cabaniss, DL1
Roose, SP1
Crammer, JL1
Elkes, A1

Other Studies

3 other studies available for desipramine and Agranulocytosis

ArticleYear
Desipramine-induced agranulocytosis. A case report.
    Drug intelligence & clinical pharmacy, 1982, Volume: 16, Issue:1

    Topics: Aged; Agranulocytosis; Desipramine; Female; Humans

1982
Late onset tricyclic-induced agranulocytosis with an atypical course.
    Pharmacopsychiatry, 1993, Volume: 26, Issue:4

    Topics: Agranulocytosis; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Humans; Leukocy

1993
Agranulocytosis after desipramine.
    Lancet (London, England), 1967, Jan-14, Volume: 1, Issue:7481

    Topics: Aged; Agranulocytosis; Desipramine; Female; Humans; Leukocyte Count; Liver Function Tests

1967